A phase 1 and pharmacodynamic study of decitabine in combination with carboplatin in patients with recurrent, platinum-resistant, epithelial ovarian cancer-Reference-Cited by-同舟云学术

A phase 1 and pharmacodynamic study of decitabine in combination with carboplatin in patients with recurrent, platinum-resistant, epithelial ovarian cancer

Published:2010-06-08 Issue:17 Volume:116 Page:4043-4053
ISSN:0008-543X
Container-title:Cancer
language:en
Short-container-title:Cancer

Author:

Fang Fang,Balch Curt,Schilder Jeanne,Breen Timothy,Zhang Shu,Shen Changyu,Li Lang,Kulesavage Carol,Snyder Anthony J.,Nephew Kenneth P.,Matei Daniela E.

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference52 articles.

1. The management of recurrent ovarian cancer;Bukowski;Semin Oncol.,2007

2. Beyond chemotherapy: targeted therapies in ovarian cancer;Yap;Nat Rev Cancer.,2009

3. First-line treatment for advanced ovarian cancer: paclitaxel, platinum and the evidence;Sandercock;Br J Cancer.,2002

4. Cancer of the ovary;Liu;N Engl J Med.,2005

5. Methylation microarray analysis of late-stage ovarian carcinomas distinguishes progression-free survival in patients and identifies candidate epigenetic markers;Wei;Clin Cancer Res.,2002

Cited by 150 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Sex difference in human diseases: mechanistic insights and clinical implications;Signal Transduction and Targeted Therapy;2024-09-10

2. Tumor editing suppresses innate and adaptive antitumor immunity and is reversed by inhibiting DNA methylation;Nature Immunology;2024-08-21

3. Targeting the epigenome with advanced delivery strategies for epigenetic modulators;Bioengineering & Translational Medicine;2024-08-17

4. Current data and future perspectives on DNA methylation in ovarian cancer (Review);International Journal of Oncology;2024-05-08

5. Apolipoprotein A-1 downregulation promotes basal-like breast cancer cell proliferation and migration associated with DNA methylation;Oncology Letters;2024-05-01